In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $37.48, denoting

Viking Therapeutics' pipeline includes several promising weight-loss candidates. The stock could soa

Viking Therapeutics, Inc. maintains a Hold rating, reflecting a balanced risk-reward at its current

NVO and VKTX stocks offer contrasting opportunities in the fast-growing obesity market, with key dif

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or H

Unlike SpaceX, ADMA Biologics is already profitable and has a clear path to doubling over the near t

Dyne is advancing therapies for rare muscle diseases while Viking targets the booming weight-loss ma

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $36.97, denoting

Viking Therapeutics jumps after it starts its first human study of VK3019, expanding its obesity pip

Viking Therapeutics launches Phase 1 trial for obesity drug VK3019, a dual amylin/calcitonin recepto

Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical compa

A global semiconductor sell-off hammered the Nasdaq on Tuesday, but a rotation into defensives and s

Lake Street analyst Daniel Brims initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a B

Oral VK2735 demonstrated early, progressive weight loss from Week 1 through Week 13 without a platea

U.S. stocks sank Monday as an Iranian drone attack on a UAE petroleum site sent Brent above $114, go

Cantor Fitzgerald analyst Steve Seedhouse maintains Viking Therapeutics (NASDAQ:VKTX) with a Over

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(1.37) per share which missed the an

HC Wainwright & Co. analyst Joseph Pantginis reiterates Viking Therapeutics (NASDAQ:VKTX) wit

U.S. equities fell broadly Wednesday as Brent Crude surged past $108 on reports of Iranian energy-fa

Viking shares rise after Novo's REDEFINE 4 trial trails Lilly's tirzepatide in weight loss.

Wall Street opened the week under heavy pressure as risk sentiment deteriorated on AI-related credit

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Viking Therapeutics (NASDAQ:VKTX) stock is soaring on Thursday, extending the momentum it picked up

VKTX: 13% | Viking Therapeutics shares are trading higher. The company reported Q4 financial results

Here's a look inside the Q4 earnings report from Viking Therapeutics.

Viking Therapeutics (NASDAQ:VKTX) reported quarterly losses of $(1.38) per share which missed the an

Investors are anticipating reports from Robinhood, Pinterest, Rivian and more. Here's a look at

U.S. stocks rallied near record territory on Thursday as blowout earnings from major Wall Street fir

Wall Street retreated Wednesday as weakness in technology and financial stocks dragged major indexes

Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral RegimensDesigned to Explore Ma

Abivax shares rise on renewed takeover speculation tied to Eli Lilly following strong Phase 3 trial

Viking Therapeutics Inc (NASDAQ:VKTX) shares are trading higher on Thursday. The clinical-stage biop